The use of antimicrobials in broilers is considered to be a cause of the appearance of vancomycin-resistant enterococci (VRE). Once VRE penetration occurs, whatever its origin, it is difficult to expel the enterococci from the intestine because of their multiple resistance, whether natural or acquired. In this study, we evaluated the prevention of VRE colonization by the dietary supplementation of a cell-wall preparation of Enterococcus faecalis strain EC-12 (EC-12) in newly hatched broilers that were challenged by experimental infection with VRE. The chicks were fed a basal diet supplemented with 0.05% (wt/wt) EC-12 powder for 15 d. The control group and that administered Lactobacillus sp. were fed the basal diet. The VRE challenge was administered orally when the chicks were 2 d old (d 0). Dietary EC-12 reduced VRE colonization in the intestine from d 3 to 14. Total IgA in the cecal digesta and total IgG in the serum were higher on d 14 in the EC-12 treatment group. However, VRE-specific and EC-12-specific antibodies were not affected in serum. Hence, it appeared that dietary EC-12 stimulated the gut immune system and reinforced the immune reaction against the VRE challenge to accelerate its defecation from the chick intestine.
The effects of a cell preparation of Enterococcus faecalis strain EC-12 (EC-12) on the digesta flow in a pig model and its oral administration to humans were examined for its effect on frequency of defecation and faecal consistency. Latin square model was used in the pig study. Three sows fistulated at the caecum were fed a diet supplemented with either EC-12 or yeast cell wall (10 mg/kg body weight per day) for 9 days. An untreated control (C) was also obtained. Four markers (two were liquid and others solid markers) were used to determine the transit time of the liquid and solid phases of digesta in the gastrointestinal tract. The use of a dual marker system was for the better understanding of the digesta kinetics. YbCl 3 and Co-EDTA were given with a morning meal, and CeCl 3 and Eu-EDTA were given with a night meal on day 8. Caecal digesta were sampled every 2 h for 48 h after morning dosing. The total bioavailabilities of the liquid markers were lower in the EC-12 group than in the C group (Co-EDTA, 72%; Eu-EDTA, 63%). The relative concentrations of chloride to the liquid markers were higher in the EC-12 group than in other groups. Eleven volunteers ingested EC-12 (600 mg/day) for 30 days. EC-12 administration increased the frequency of defecation on day 30 in comparison with day 0. EC-12 stimulates the inflammatory reactions that relate ion and water secretion from the intestine. Accordingly, EC-12 may aid in the recovery from constipation through an acceleration of the liquid digesta flow in the large intestine.
The effect of Lactobacillus plantarum SNK12 (CPLP) supplementation on mRNA levels of hippocampal neurotrophic factors and gamma aminobutyric acid receptors (GABAR) was tested. In Experiment 1, stress-free, unsupplemented and CPLP (4 × 108 cells/head)-supplemented male C57BL/6J (B6) mice were the experimental animals. In Experiment 2, intruder (male, B6) mice [negative control; unsupplemented, sub-chronic mild social defeat stress (sCSDS)-induced; and CPLP-supplemented, sCSDS-induced] were exposed to aggressor mice (adult male Slc:ICR). mRNA levels of neurotrophic factors and GABAR in hippocampal samples of these mice were analyzed. In CPLP-supplemented mice of both experiments, mRNA levels of bdnf, nt-3, and GABAR were upregulated. Moreover, a tendency toward the improvement of habituation ability (Experiment 1) and behavior (Experiment 2) was observed in mice, which may be associated with upregulated neurotrophic factors and GABAR. We demonstrated that oral supplementation of CPLP to stress-free and stress-induced mice upregulated mRNA levels of hippocampal neurotrophic factors and GABAR.
The effects of the consumption (200 mg/day) of heat-killed Enterococcus faecalis EC-12 preparation (EC-12) for 14 days on microbiota and metabolic activity of the faeces were studied in eight healthy volunteers (22 Á/26 years of age). During EC-12 consumption, the counts of bifidobacteria (p B/0.05 on day 7 and p B/0.01 on day 14) were significantly increased, except for the numbers of bifidobacteria in one volunteer, whereas the counts and the frequency of occurrence of lecithinase-positive clostridia (p B/0.05), including Clostridium perfringens, were significantly decreased, when compared with the values before EC-12 consumption and during placebo consumption. The decreased tendency in the counts of Enterobacteriaceae and the increased tendency in the levels of lactobacilli was observed during EC-12 consumption, compared with the values before EC-12 consumption and during placebo consumption. No detectable changes occurred in the counts of other organisms throughout the experimental periods. The total faecal volatile fatty acid and acetic acid (p B/0.05 on day 7 and p B/0.01 on day 14) during EC-12 consumption, and succinic acid (p B/0.05), lactic acid (p B/0.05) and propionic acid (p B/0.05) on day 14 of EC-12 consumption were significantly increased when compared with the values before EC-12 consumption and during placebo consumption. Faecal concentrations of ammonia, phenol and p-cresol (p B/0.05) were significantly decreased on day 14 of EC-12 consumption. Faecal levels of sulfide and indole (p B/0.05) were significantly decreased during EC-12 consumption. Faecal values of oxidation-reduction potential (ORP; p B/0.05 on day 7 and p B/0.01 on day 14) were significantly decreased during EC-12 consumption. Faecal pH values tended to decrease on day 14 of EC-12 consumption. Stool weight and water content were slightly increased during EC-12 consumption. The odour of the faeces was slightly reduced during EC-12 consumption.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.